Table 2.
Laboratory parameters of all cases with metabolic syndrome (MetS).
| Median (min.-max.) | ||||
|---|---|---|---|---|
| All cases (n : 191) | Female (n : 123) | Male (n : 68) | p | |
| Fasting blood glucose (mg/dL) | 127 (42.0–394) | 127 (42–394) | 129 (62–384) | 0.756 |
| HbA1c (%) | 7 (5.20–12.7) | 6.9 (5.4–12.7) | 7 (5.2–12.4) | 0.750 |
| HOMA-IR | 2.64 (0.64–20.2) | 2.45 (0.64–20.2) | 3.18 (0.77–10.6) | 0.242 |
| Total cholesterol (mg/dL) | 192 (103–347) | 191 (103–342) | 193 (118–347) | 0.604 |
| HDL-cholesterol (mg/dL) | 45 (22–96) | 48 (27–96) | 42 (22–82) | <0.001 |
| LDL-cholesterol (mg/dL) | 114 (27–400) | 114 (27–400) | 113 (43–215) | 0.639 |
| Triglyceride (mg/dL) | 145 (45–1245) | 144 (47–451) | 144 (45–1245) | 0.812 |
| TSH (uIU/mL) | 1.58 (0.50–4.50) | 1.65 (0.57–4.5) | 1.37(0.5–4.5) | 0.031 |
| Free-T3 (pg/mL) | 3.11 (0.07–4.02) | 3.07 (0.07–4.02) | 3.17 (2.35–3.86) | 0.109 |
| Free-T4 (ng/mL) | 0.87 (0.46–3.40) | 0.87 (0.46–3.4) | 0.85 (0.62–1.37) | 0.240 |
| Anti-TPO (IU/mL) | 0.6 (0.10–170) | 0.7 (0.1–170) | 0.6 (0.2–86) | 0.236 |
| Anti-TG (IU/mL) | 0.9 (0.90–722) | 0.9 (0.9–456) | 0.9 (0.9–722) | 0.042 |
| Hemoglobin (g/dL) | 13.8 (11.0–17.8) | 12.8 (11–15.6) | 14.9 (11–17.8) | <0.001 |
| Uric acid (mg/dL) | 4.8 (1.80–9.30) | 4.45 (1.8–9.3) | 5.2 (2.8–8.6) | 0.004 |
| eGFR (mL/min/1.73 m2) | 94.3 (41.3–194) | 101 (46–193) | 78 (41–153) | <0.001 |
| Serum creatinine (mmol/L) | 0.76 (0.38–1.50) | 0.69 (0.38–1.25) | 0.91 (0.62–1.50) | <0.001 |
| Microalbumin in spot urine (mg/L) | 1.21 (0.09–230) | 1.21 (0.09–179) | 1.27(0.30–230) | 0.798 |
HOMA-IR: the homeostatic model assessment-insulin resistance, eGFR: estimated glomerular filtration rate. p < 0.05 was considered significant.